BioSpecifics Technologies CEO J Buchi receives $1.9M in 2019
BioSpecifics Technologies reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
BioSpecifics Technologies reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at BioSpecifics Technologies received on average a compensation package of $764K, a 91% increase compared to previous year.
Average pay of disclosed executives at BioSpecifics Technologies
J. Kevin Buchi, Chief Executive Officer, received $1.9M in total. 87% of Buchi's compensation, or $1.6M, was in option awards. Buchi also received $90K in non-equity incentive plan, $139K in salary, as well as $6.4K in other compensation.
Patrick Caldwell, Former Interim Principal Financial Officer, received a compensation package of $424K. 87% of the compensation package, or $367K, was in salary.
Thomas Wegman, Former President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, earned $412K in 2019, a 3% increase compared to previous year.
Ronald Law, Former Interim Principal Executive Officer, received $366K in 2019.
Related executives
J Buchi
BioSpecifics Technologies
Chief Executive Officer
Thomas Wegman
BioSpecifics Technologies
Former President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
Ronald Law
BioSpecifics Technologies
Former Interim Principal Executive Officer
Patrick Caldwell
BioSpecifics Technologies
Former Interim Principal Financial Officer
You may also like
Source: SEC filing on April 29, 2020.